Dapirolizumab Biosimilar – Anti-CD40LG, CD154 mAb – Research Grade

Reference:
Product nameDapirolizumab Biosimilar - Anti-CD40LG, CD154 mAb - Research Grade
SourceCAS 1416147-64-2
SpeciesHumanized
Purity>85%
BufferPBS buffer PH7.5
Delivery conditionBlue ice (+4°C)
Delivery Time3-5 days if in stock; 3-5 weeks if production needed
Storage conditionstore at -80°C
BrandProteoGenix
ApplicationsELISA,WB
Aliases /SynonymsDapirolizumab,CDP7657,CD40LG, CD154,anti-CD40LG, CD154
ReferencePX-TA1337
NoteFor research use only. Not suitable for clinical or therapeutic use.
IsotypeFab'-G1-kappa
ClonalityMonoclonal Antibody

Description of Dapirolizumab Biosimilar - Anti-CD40LG/CD154 mAb - Research Grade

General information on Anti-CD40LG/CD154[Homo sapiens] (Dapirolizumab) Monoclonal Antibody

Dapirolizumab is investigated for the treatment of Systemic Lupus Erythematosus.

Reviews

There are no reviews yet.

REVIEW YOUR PRODUCT

Be the first to review “Dapirolizumab Biosimilar – Anti-CD40LG, CD154 mAb – Research Grade”

Your email address will not be published. Required fields are marked *

Related products

CD40 ligand(CD40LG)
Antigen

CD40 ligand(CD40LG)

PX-P4855 221$
Stable Isotope Labelled Dapirolizumab Biosimilar – Anti-CD40LG/CD154 mAb – Research Grade
SIL

Stable Isotope Labelled Dapirolizumab Biosimilar – Anti-CD40LG/CD154 mAb – Research Grade

PX-TA1337-SIL 15750$

Contact us

Send us a message from the form below







    Cart (0 Items)

    Your cart is currently empty.

    View Products